Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Synthesis of Sheet Like Nanostructures of NiO Using Potassium Dichromate as Surface Modifying Agent for the Sensitive and Selective Determination of Amlodipine Besylate (ADB) Drug

View through CrossRef
AbstractThe monitoring of hypertension drugs is very critical and important to sustain a healthy life. In this study, we have synthesized nickel oxide (NiO) nanostructures using potassium dichromate as surface modifying agent by hydrothermal method. These NiO nanostructures were found highly active for the oxidation of ADB besylate (ADB). The unit cell structure and morphology were investigated by scanning electron microscopy (SEM) and powder X‐ray diffraction (XRD) techniques. The SEM study has confirmed the nano sheet like morphology and XRD analysis has described the cubic unit arrays of NiO. After the physical characterization, NiO nanostructures were used to modify the surface of glassy carbon electrode (GCE) by drop casting method. Then cyclic voltammetry (CV) was used to characterize the electrochemical activity of NiO nanostructures in the0.1 M phosphate buffer solution of pH 10.0 and a well resolved oxidation peak was identified at 0.70 V. The linear range for the NiO nanostructures was observed from 20–90 nM with a regression coefficient of 0.99 using CV. The calculated limit of detection (LOD) was 2.125 nM and the limit of quantification (LOQ) was 4.08 nM. Further to validate the CV calibration plot, an amperometry experiment was performed on the NiO nanostructures and sensors exhibited a linear range of 10 nM to 115 nM with LOD of 1.15 nM. The proposed approach was successfully used for the determination of ADB from commercial tablets and it reveals that the sensor could be capitalized to monitor ADB concentrations from pharmaceutical products. The use of potassium dichromate as a surface modifying agent for the metal oxide nanostructures may be of great interest to manipulate their crystal and surface properties for the extended range of biomedical and energy related applications.
Title: Synthesis of Sheet Like Nanostructures of NiO Using Potassium Dichromate as Surface Modifying Agent for the Sensitive and Selective Determination of Amlodipine Besylate (ADB) Drug
Description:
AbstractThe monitoring of hypertension drugs is very critical and important to sustain a healthy life.
In this study, we have synthesized nickel oxide (NiO) nanostructures using potassium dichromate as surface modifying agent by hydrothermal method.
These NiO nanostructures were found highly active for the oxidation of ADB besylate (ADB).
The unit cell structure and morphology were investigated by scanning electron microscopy (SEM) and powder X‐ray diffraction (XRD) techniques.
The SEM study has confirmed the nano sheet like morphology and XRD analysis has described the cubic unit arrays of NiO.
After the physical characterization, NiO nanostructures were used to modify the surface of glassy carbon electrode (GCE) by drop casting method.
Then cyclic voltammetry (CV) was used to characterize the electrochemical activity of NiO nanostructures in the0.
1 M phosphate buffer solution of pH 10.
0 and a well resolved oxidation peak was identified at 0.
70 V.
The linear range for the NiO nanostructures was observed from 20–90 nM with a regression coefficient of 0.
99 using CV.
The calculated limit of detection (LOD) was 2.
125 nM and the limit of quantification (LOQ) was 4.
08 nM.
Further to validate the CV calibration plot, an amperometry experiment was performed on the NiO nanostructures and sensors exhibited a linear range of 10 nM to 115 nM with LOD of 1.
15 nM.
The proposed approach was successfully used for the determination of ADB from commercial tablets and it reveals that the sensor could be capitalized to monitor ADB concentrations from pharmaceutical products.
The use of potassium dichromate as a surface modifying agent for the metal oxide nanostructures may be of great interest to manipulate their crystal and surface properties for the extended range of biomedical and energy related applications.

Related Results

Structural and Optical Properties of Pure NiO Nanoparticles and NiO-Mn2O3, NiO-CdO, NiO-Pb2O3, NiO-ZnO Nanocomposites
Structural and Optical Properties of Pure NiO Nanoparticles and NiO-Mn2O3, NiO-CdO, NiO-Pb2O3, NiO-ZnO Nanocomposites
Abstract: Pure nickel oxide (NiO) nanoparticles and NiO-Mn2O3, NiO-CdO, NiO-Pb2O3, NiO –ZnO nanocomposites were synthesized by co-precipitation method. The PXRD studies revealed th...
Comparison of Microemulsion and Solvent Evaporation Technique for Solubility Enhancement of Amlodipine Besylate
Comparison of Microemulsion and Solvent Evaporation Technique for Solubility Enhancement of Amlodipine Besylate
Introduction: Amlodipine besylate is a calcium channel blocker indicated for hypertension and angina. It is described as slightly soluble in water and due to its limited solubility...
Electrophoretic Deposition and Physicochemical Characterization of Al2O3-NiO Composite Materials
Electrophoretic Deposition and Physicochemical Characterization of Al2O3-NiO Composite Materials
Al2O3-NiO composites were fabricated by electrophoretic deposition (EPD). Suspensions were prepared from the mixture of Al2O3 and NiO powder in a mixed ethanol-water electrolyte an...
Potentiometric Zinc Ion Sensor Based on Honeycomb-Like NiO Nanostructures
Potentiometric Zinc Ion Sensor Based on Honeycomb-Like NiO Nanostructures
In this study honeycomb-like NiO nanostructures were grown on nickel foam by a simple hydrothermal growth method. The NiO nanostructures were characterized by field emission electr...
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
BACKGROUND As of July 2020, a Web of Science search of “machine learning (ML)” nested within the search of “pharmacokinetics or pharmacodynamics” yielded over 100...
Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects
Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects
Abstract Background To investigate the effects of coadministration of esaxerenone with amlodipine on the pharmacokinetics (PK) of each drug, and of esaxerenone on the PK of digoxin...

Back to Top